The main goal of Dr. Stephania Cormier laboratory is to determine if exposure during early life to environmental factors (i.e. allergens, pollutants, and respiratory viruses) leads to predisposition, development of, or exacerbation of respiratory disease in the adult. In the short term, they seek: (1) to define the cellular and molecular changes in the pulmonary microenvironment following gestational and/or neonatal exposure; (2) to determine if urban pollutants (e.g. particulates such as diesel exhaust particles), initiate cellular/molecular events in the developing lung which lead to increased susceptibility to airways disease later in life; (3) to define the impact of respiratory viral infection on pulmonary pathophysiology of the infant; and (4) to understand how urban pollutants impact host defense resulting in enhanced morbidity and increased mortality from respiratory infections.
M-LEEaD CenterIn Utero Exposures to E-cigarettes: implications for childhood obesity
M-LEEaD Center Winter Seminar Series: Stephania Cormier, PhD
January 30, 2019
12:05 pm - 1:00 pm
1655 SPH I
1415 Washington Heights
Ann Arbor, MI 48109-2029
Sponsored by: M-LEEaD Center
Contact Information: Michelle Dauod lowdenm@umich.edu
The main goal of Dr. Stephania Cormier laboratory is to determine if exposure during early life to environmental factors (i.e. allergens, pollutants, and respiratory viruses) leads to predisposition, development of, or exacerbation of respiratory disease in the adult. In the short term, they seek: (1) to define the cellular and molecular changes in the pulmonary microenvironment following gestational and/or neonatal exposure; (2) to determine if urban pollutants (e.g. particulates such as diesel exhaust particles), initiate cellular/molecular events in the developing lung which lead to increased susceptibility to airways disease later in life; (3) to define the impact of respiratory viral infection on pulmonary pathophysiology of the infant; and (4) to understand how urban pollutants impact host defense resulting in enhanced morbidity and increased mortality from respiratory infections.
